Cargando…
Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
Treprostinil is a prostacyclin analogue that targets multiple cellular receptors to treat pulmonary arterial hypertension (PAH). In certain scenarios, patients may require aggressive treprostinil titration. Several studies have demonstrated that higher doses of treprostinil lead to greater clinical...
Autores principales: | Kingrey, John F., Miller, Chad E., Franco, Veronica, Smith, Jimmy S., Zolty, Ronald, Oudiz, Ronald J., Elwing, Jean M., Huston, Jessica H., Melendres‐Groves, Lana, Ravichandran, Ashwin, Balasubramanian, Vijay, Wu, Benjamin, Hwang, Stephanie, Seaman, Scott, Broderick, Meredith, Rahaghi, Franck F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368085/ https://www.ncbi.nlm.nih.gov/pubmed/37497167 http://dx.doi.org/10.1002/pul2.12255 |
Ejemplares similares
-
Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022) -
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013) -
Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021) -
The Rapid Initiation, Titration, and Transition from Intravenous to Oral Treprostinil in a Patient with Severe Pulmonary Arterial Hypertension
por: Gleason, James Benjamin, et al.
Publicado: (2015) -
Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation
por: Rahaghi, Franck F., et al.
Publicado: (2017)